Alemtuzumab 30mg/1ml solution for infusion vials
previously Alemtuzumab 30mg/1ml solution for injection vials
- SNOMED code
9188011000001102- Named
- Active compound
- Alemtuzumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
previously
rINN - Recommended International Non-proprietary - Prescribable
- Caution - AMP level prescribing advised
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 1 ml, vial
- Ingredients
- Alemtuzumab
— 30 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninfusion.intravenous
Solution for infusion, Intravenous - Controlled drug
- No Controlled Drug Status
Products
MabCampath 30mg/1ml concentrate for solution for infusion vials (Genzyme Therapeutics Ltd)
in short MabCampath 30mg/1ml concentrate for inf vials
previously MabCampath Concentrate 30mg/1ml solution for injection vials
MabCampath 30mg/1ml concentrate for solution for infusion vials
- SNOMED code
9188211000001107- Named
- Supplier
- Genzyme Therapeutics Ltd
- Licensed as
- None
- Earlier licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed route
- Intravenous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
MabCampath 30mg/1ml concentrate for solution for infusion vials (Genzyme Therapeutics Ltd) 3 vial9188311000001104 ref. pack |
Discontinued
Legal category: POM | 5030045000296 | No Price Available previously: £792.34 | • Personally Administered • Hospital |
| — |
Reference packs
Alemtuzumab 30mg/1ml solution for infusion vials 3 vial
- SNOMED code
9188111000001101- Quantity and unit
- 3 vial
- Packs